As Director of the Phase 1 Unit of the Clinical Pharmacological Research Center at Peking Union Medical College, Dr. Pei Hu has been a driving force in advancing model-based drug development in China. Dr. Hu discusses recent changes impacting clinical research in China and her service as co-chair of our <a href="https://www.diaglobal.org/en/conference-listing/meetings/2018/05/10th-dia-china-annual-meeting" target="_blank">10th DIA China Annual Meeting </a>in Beijing.

As Director of the Phase 1 Unit of the Clinical Pharmacological Research Center at Peking Union Medical College, Dr. Pei Hu has been a driving force in advancing model-based drug development in China. Dr. Hu discusses recent changes impacting clinical research in China and her service as co-chair of our 10th DIA China Annual Meeting in Beijing.

As Director of the Phase 1 Unit of the Clinical Pharmacological Research Center at Peking Union Medical College, Dr. Pei Hu has been a driving force in advancing model-based drug development in China. Dr. Hu discusses recent changes impacting clinical research in China and her service as co-chair of our <a href="https://www.diaglobal.org/en/conference-listing/meetings/2018/05/10th-dia-china-annual-meeting" rel="noopener noreferrer">10th DIA China Annual Meeting </a>in Beijing.

Changing Research in China: From Generics to Innovators

DIA is a global, multidisciplinary, membership association of healthcare professionals that works towards the advancement of lifesaving medicines, therapies, and technologies around the world.

Share Changing Research in China: From Generics to Innovators

Sign up to save your podcasts

Changing Research in China: From Generics to Innovators

Changing Research in China: From Generics to Innovators